Determinants of adherence to diabetes treatment

Journal of Diabetes

Volumn 7, Issue 6, 2015, Pages 864-871

  Larkin, Amy T ^a   Hoffman, Christina ^a   Stevens, Adrienne ^b   Douglas, Andrew ^c   Bloomgarden, Zachary ^d  

^a Medscape Education   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c WebMD Health Services   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Disease management; Education; Medication adherence; Patient

Indexed keywords

ORAL ANTIDIABETIC AGENT; ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BODY WEIGHT DISORDER; CONSCIOUSNESS; DIABETIC PATIENT; DRUG DOSE TITRATION; FACTORIAL ANALYSIS; FEMALE; HEALTH SURVEY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; SELF CARE; SELF MONITORING; SELF REPORT; STOMACH DISEASE; UNITED STATES; WEIGHT GAIN; ATTITUDE TO HEALTH; BLOOD; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DOCTOR PATIENT RELATION; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; HEALTH CARE SURVEY; INTERPERSONAL COMMUNICATION; MEDICATION COMPLIANCE; METABOLISM; MIDDLE AGED; PERCEPTION; QUESTIONNAIRE; TREATMENT OUTCOME;

BIOMARKERS; BLOOD GLUCOSE; COMMUNICATION; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PERCEPTION; PHYSICIAN-PATIENT RELATIONS; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84945436077     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12264     Document Type: Article

References (32)

1. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008; 359: 1577-1589.
2. Mayberry LS, Gonzalez JS, Wallston KA, Kripalani S, Osborn CY. The ARMS-D out performs the SDSCA, but both are reliable, valid, and predict glycemic control. Diabetes Res Clin Pract. 2013; 102: 96-104.
3. Currie CJ, Peyrot M, Morgan CL etal. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care. 2012; 35: 1279-1284.
4. Blonde L. Current challenges in diabetes management. Clin Cornerstone. 2005; 7 (Suppl. 3): S6-S17.
5. Vinik A. Too many notes: Up and down the scales of diabetes therapy. Clin Ther. 2007; 29: 1227-1235.
6. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: A retrospective cohort study. Diabet Med. 2002; 19: 279-284.
7. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA. 2002; 288: 2868-2879.
8. Van Gaal LF, De Leeuw IH. Rationale and options for combination therapy in the treatment of Type 2 diabetes. Diabetologia. 2003; 46 (Suppl. 1): M44-50.
9. Peyrot M, Rubin RR, Kruger DF, Travis LB. Correlates of insulin injection omission. Diabetes Care. 2010; 33: 240-245.
10. Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: A systematic review. Diabet Med. 2013; 30: 512-524.
11. Bergenstal RM. Treatment models from the International Diabetes Center: Advancing from oral agents to insulin therapy in type 2 diabetes. Endocr Pract. 2006; 12 (Suppl. 1): 98-104.
12. Rakel RE. Improving patient acceptance and adherence in diabetes management: A focus on insulin therapy. Adv Ther. 2009; 26: 838-846.
13. Colombi AM, Yu-Isenberg K, Priest J. The effects of health plan copayments on adherence to oral diabetes medication and health resource utilization. J Occup Environ Med. 2008; 50: 535-541.
14. Piette JD, Heisler M, Wagner TH. Problems paying out-of-pocket medication costs among older adults with diabetes. Diabetes Care. 2004; 27: 384-391.
15. Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004; 42: 626-634.
16. Choudhry NK, Avorn J, Glynn RJ etal. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011; 365: 2088-2097.
17. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care. 1997; 20: 1512-1517.
18. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001; 23: 1296-1310.
19. Williams A, Manias E. Exploring motivation and confidence in taking prescribed medicines in coexisting diseases: A qualitative study. J Clin Nurs. 2014; 23: 471-481.
20. Guénette L, Moisan J, Breton MC, Sirois C, Grégoire JP. Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance. Diabetes Metab. 2013; 39: 250-257.
21. Polonsky WH. Understanding and assessing diabetes-specific quality of life. Diabetes Spectrum. 2000; 13: 36-41.
22. Lin EH, Katon W, Von Korff M etal. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004; 27: 2154-2160.
23. Kalsekar ID, Madhavan SS, Amonkar MM etal. Depression in patients with type 2 diabetes: Impact on adherence to oral hypoglycemic agents. Ann Pharmacother. 2006; 40: 605-611.
24. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Arch Intern Med. 2000; 160: 3278-3285.
25. Kilbourne AM, Reynolds CF 3rd, Good CB, Sereika SM, Justice AC, Fine MJ. How does depression influence diabetes medication adherence in older patients? Am J Geriatr Psychiatry. 2005; 13: 202-210.
26. Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC LCA: A SAS procedure for latent class analysis. Struct Equ Modeling. 2007; 14: 671-694.
27. Muthén B. Latent variable mixture modeling. In: Coulides GA, Schumacher RE (eds). New Developments and Techniques in Structural Equation Modeling. Lawrence Erlbaum Associates, Hillsdale, NJ, 2001, 1-33.
28. Reaven GM, Miller RG. An attempt to define the nature of chemical diabetes using a multidimensional analysis. Diabetologia. 1979; 16: 17-24.
29. Hoffman DL, Franke GR. Correspondence analysis: Graphical representation of categorical data inketing research. J Mark Res. 1986; 23: 213-227.
30. U.S. Department of Health and Human Services. 2013 Annual Progress Report to Congress: National Strategy for Quality Improvement in Health Care. Agency for Healthcare Research and Quality, Rockville, MD, 2013, Available from: http://www.ahrq.gov/workingforquality/nqs/nqs2013annlrpt.htm (accessed 29 April 2014).
31. Bloomgarden Z, Dagogo-Jack S. Five Ms of adherence. J Diabetes. 2011; 3: 169-171.
32. Gonzalez J, Schneider HE, Wexler DJ etal. Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care. 2013; 36: 831-837.